1. Volume 149, Issue 1, Pages 157-162 (March 2000)
Insulin-like growth factor binding protein-1 (IGFBP-1) and IGF-I during oral and transdermal estrogen replacement therapy: relation to lipoprotein(a) levels 
Marita Paassilta, Anna Karjalainen, Kari Kervinen, Markku J Savolainen, Jorma Heikkinen, Ann-Christine Bäckström, Y.Antero Kesäniemi 
Atherosclerosis 
Volume 149, Issue 1, Pages (March 2000)
DOI: /S (99)

2. Fig. 1
Plasma levels of Lp(a) (Panel A), IGF-I (Panel B) and IGFBP-1 (Panel C) during the 6-month ERT in postmenopausal women, presented in percentage values (S.E.M.) from the baseline level. Closed squares represent the oral treatment group (n=35) (P-values for the overall difference from the baseline values indicated by ANOVA), whereas open squares represent the transdermal treatment group (n=38) (NS by ANOVA).
Atherosclerosis  , DOI: ( /S (99) )

3. Fig. 2
Spearman correlation between the absolute changes (baseline to 6 months of ERT) in plasma Lp(a) levels and IGFBP-1 levels during the oral ERT (n=35).
Atherosclerosis  , DOI: ( /S (99) )